Medifron DBT Co. Ltd (065650) — Cash Flow Quality Index

Latest as of June 2025: 1.25x

Medifron DBT Co. Ltd (065650) has a Cash Flow Quality Index of 1.25x as of June 2025. Operating cash flow of ₩6.72 Billion exceeds net income of ₩5.37 Billion, indicating high earnings quality where cash backs reported profits. Explore Medifron DBT Co. Ltd (065650) cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

1.25x
Operating CF / Net Income

Operating Cash Flow

₩6.72 Billion
KRW

Net Income

₩5.37 Billion
KRW

Data as of

Jun 2025
Most recent filing

Medifron DBT Co. Ltd Cash Flow Quality Index (2011–2011)

Historical Cash Flow Quality Index for Medifron DBT Co. Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 065650 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Medifron DBT Co. Ltd (2011–2011)

Year-by-year earnings quality comparison for Medifron DBT Co. Ltd. For live market cap and the full company financial profile, see market cap of Medifron DBT Co. Ltd.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2011 1.33x ₩912.56 Million ₩684.16 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.